Immunotherapy Drugs Market Growth, Demand and Challenges of the Key Industry Players 2023-2028

1
Global Immunotherapy Drugs Market Research and
Forecast Report 2023-2028




Author Elena Anderson Marketing Manager IMARC
Group
2022 IMARC All Rights Reserved
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2
About IMARC Group
Report Description
International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all regions
and industry verticals to identify their
highest-value opportunities, address their most
critical challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Immunotherapy Drugs Market Research
Report 2023-2028 According to the latest report
by IMARC Group, titled "Immunotherapy Drugs
Market by Type (Monoclonal Antibodies, Vaccines,
Interferons Alpha and Beta, Interleukins),
Therapy Area (Cancer, Autoimmune and Inflammatory
Diseases, Infectious Diseases, and Others), End
User (Hospitals, Clinics, and Others), and Region
2023-2028," the global immunotherapy drugs market
size reached US 195.4 Billion in
2022. Immunotherapy drugs refer to specialized
medications used for treating a range of
conditions, including lymphoma, melanoma,
sarcoma, and lung, bladder, kidney, and breast
cancer. These drugs stimulate the body's natural
defenses by targeting and activating specific
immune cells, such as T-cells, triggering an
immunological response that aids in generating
antibodies that prevent the growth of cancer
cells. They also help fight against allergies
and infections caused by bacteria and viruses.
Some of the standard immunotherapy drugs
available in the market include checkpoint
inhibitors, monoclonal antibodies, and cancer
vaccines. They provide long-lasting and sometimes
permanent responses with fewer side effects than
traditional chemotherapy and radiation
treatments.

4
Report Description and Highlights
Report Description
As a result, immunotherapy drugs are becoming
widely accepted and popular across the
globe. Request for a PDF sample of this report
https//www.imarcgroup.com/immunotherapy-drugs-mar
ket/requestsample

5
Report Description and Highlights
Report Description
Global Immunotherapy Drugs Market Trends The
widespread prevalence of cancer, tumor, and
target diseases and the expanding geriatric
population are primarily driving the global
immunotherapy drugs market growth. Besides this,
the rising incidences of genetic and lifestyle
diseases due to the adoption of sedentary
lifestyles and hectic schedules are supporting
the market growth. Moreover, the shifting
consumer preference for immunotherapy drugs that
can be customized based on the patient's genetic
profile and tailored to their individual needs to
improve treatment outcomes is acting as another
significant growth-inducing factor. Additionally,
the enhancing popularity of antibodies and
biosimilar drugs, the rise in the number of
hospitals, pharmacies, and research laboratories,
and extensive investments in research and
development (RD) activities to enhance the
formulation of immunotherapy drugs are creating a
favorable outlook for the market. Furthermore,
the escalating focus on strategic collaborations
and new product developments by key market
players to expand their product portfolio and
gain a competitive edge is contributing to the
market growth. Other factors, such as rising
healthcare expenditure, a growing number of
clinical trials, easy availability of favorable
reimbursement policies, and significant
advancements in companion diagnostics, are
presenting remunerative growth opportunities for
the market.

6
Report Description and Highlights
Report Description
Looking forward, the market value is projected
to reach US 327.8 Billion by 2028, expanding at
a CAGR of 8.9 during 2023-2028. View Report
TOC, Figures and Tables https//www.imarcgroup.co
m/immunotherapy-drugs-market

7
Report Description and Highlights
Report Description

• Key Market Segmentation
• The research report includes the following
  segments
• Breakup by Type
• Monoclonal Antibodies
• Vaccines
• Interferons Alpha and Beta
• Interleukins
•  
• Breakup by Therapy Area
• Cancer
• Autoimmune and Inflammatory Diseases
• Infectious Diseases
• Others
• Breakup by End User
• Hospitals
• Clinics
• Others

8
Report Description and Highlights
Report Description

•  
• Breakup by Region
• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa
• Competitive Landscape with Key Players
• AstraZeneca plc
• Bayer AG
• Boehringer Ingelheim International GmbH
• Bristol-Myers Squibb Company
• F. Hoffmann-La Roche AG
• GSK plc
• Merck Co. Inc
• Pfizer Inc
• Sanofi S.A

9
Key Questions Answered in the Report
Report Description

• How has the global immunotherapy drugs market
  performed so far and how will it perform in the
  coming years?
• What has been the impact of COVID-19 on the
  global immunotherapy drugs market?
• What are the key regional markets?
• What is the breakup of the market based on the
  type?
• What is the breakup of the market based on the
  therapy area?
• What is the breakup of the market based on the
  end user?
• What are the various stages in the value chain of
  the industry?
• What are the key driving factors and challenges
  in the industry?
• What is the structure of the global immunotherapy
  drugs market and who are the key players?
• What is the degree of competition in the
  industry?
•  

10
Table of Contents
Report Description
1    Preface2    Scope and Methodology    2.1
   Objectives of the Study    2.2  
 Stakeholders    2.3    Data Sources       
2.3.1    Primary Sources        2.3.2  
 Secondary Sources    2.4    Market Estimation 
      2.4.1    Bottom-Up Approach        2.4.2  
 Top-Down Approach    2.5    Forecasting
Methodology3    Executive Summary4  
 Introduction    4.1    Overview    4.2    Key
Industry Trends5    Global Immunotherapy Drugs
Market    5.1    Market Overview    5.2  
 Market Performance    5.3    Impact of
COVID-19    5.4    Market Forecast

11
Table of Contents
Report Description
6    Market Breakup by Type    6.1    
Monoclonal Antibodies        6.1.1 Market
Trends        6.1.2 Market Forecast    6.2    
Vaccines        6.2.1 Market Trends       
6.2.2 Market Forecast    6.3     Interferons
Alpha and Beta        6.3.1 Market Trends     
  6.3.2 Market Forecast    6.4    
Interleukins        6.4.1 Market Trends       
6.4.2 Market Forecast7    Market Breakup by
Therapy Area    7.1     Cancer        7.1.1
Market Trends        7.1.2 Market Forecast     
    Click here to visit the complete table of
content with list of figures and tables
https//www.imarcgroup.com/immunotherapy-drugs-mar
ket/toc

12
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
13
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
14
Report Description and Highlights
Report Description

2022 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
15

Contact Us